Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
To accelerate the development of next-generation radioconjugates to treat cancer
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The company will provide comprehensive response to USFDA for the observations
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Subscribe To Our Newsletter & Stay Updated